We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

112 hedge funds and large institutions have $26M invested in SANGAMO THERAPEUTICS INC in 2026 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 16

81% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 16

12.82% more ownership

Funds ownership: 18.5% → 31.32% (+13%)

7% more funds holding

Funds holding: 105 → 112 (+7)

9% more call options, than puts

Call options by funds: $344K | Put options by funds: $315K

0% less capital invested

Capital invested by funds: $26.2M → $26M (-$127K)

Holders
112
Holders Change
+7
Holders Change %
+6.67%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
30
Reduced
16
Closed
16
Calls
$344K
Puts
$315K
Net Calls
+$29K
Net Calls Change
+$48K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$16.1M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$2.1M
3
Bank of America
Bank of America
North Carolina
+$694K
4
UBS Group
UBS Group
Switzerland
+$615K
5
Two Sigma Investments
Two Sigma Investments
New York
+$603K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$1.83M
2
Jane Street
Jane Street
New York
-$1.16M
3
WA
Wasatch Advisors
Utah
-$595K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$179K
5
GCM
Graham Capital Management
Connecticut
-$135K
Name Holding Trade Value Shares
Change 		Change in
Stake
C
76
Certuity
Florida
$3.63K +$5.85K +14,700 New
KAS
77
Kestra Advisory Services
Texas
$3.62K +$5.83K +14,643 New
SAW
78
Signal Advisors Wealth
Michigan
$3.6K +$5.81K +14,600 New
IA
79
IFP Advisors
Florida
$3.33K +$5.38K +13,509 New
BW
80
BXM Wealth
Colorado
$3.05K -$40 -100 -0.8%
IWM
81
IHT Wealth Management
Illinois
$2.96K – – –
CA
82
Cannon Advisors
North Carolina
$2.9K – – –
RSF
83
Rik Saylor Financial
Ohio
$2.84K +$4.58K +11,500 New
Focus Partners Wealth
84
Focus Partners Wealth
Massachusetts
$2.72K – – –
MFG
85
Magnus Financial Group
New York
$2.47K – – –
Rockefeller Capital Management
86
Rockefeller Capital Management
New York
$1.95K +$1.99K +5,000 +172%
Osaic Holdings
87
Osaic Holdings
Arizona
$1.73K -$60 -150 -2%
FCMT
88
Founders Capital Management (Texas)
Texas
$1.48K -$3.18K -8,000 -57%
NFSG
89
Newbridge Financial Services Group
Florida
$1.48K +$2.39K +6,000 New
DWS
90
Dynamic Wealth Strategies
California
$1.38K – – –
Royal Bank of Canada
91
Royal Bank of Canada
Ontario, Canada
$1K +$165 +414 +10%
Optiver Holding
92
Optiver Holding
Netherlands
$790 – – –
LSA
93
Leonteq Securities AG
Switzerland
$558 – – –
BLC
94
Brown, Lisle/Cummings
Rhode Island
$377 – – –
AWM
95
Activest Wealth Management
Florida
$247 – – –
AF
96
Allworth Financial
California
$247 – – –
APW
97
Atlantic Private Wealth
North Carolina
$247 – – –
TPWA
98
Twin Peaks Wealth Advisors
California
$247 +$398 +1,000 New
JP Morgan Chase
99
JP Morgan Chase
New York
$150 – – –
LFG
100
Larson Financial Group
Missouri
$109 +$135 +340 +340%
2 3
4
5 6

SGMO Hedge Fund Activity: Q1 2026 in Review

112 of the 8,142 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q1 2026, worth a combined $26M — down 0.48% from $26.2M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new SGMO positions and 16 closed out — a net gain of 13 holders — while 30 added to existing stakes and 16 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $16.1M. The largest seller was Renaissance Technologies, cutting an estimated $1.83M.

  • 112 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q1 2026, up from 105 in Q4 2025.
  • Funds reported $26M of SANGAMO THERAPEUTICS INC stock for Q1 2026, down 0.48% quarter-over-quarter.
  • 29 funds opened new SANGAMO THERAPEUTICS INC positions in Q1 2026 and 16 closed out, a net change of +13 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q1 2026 was Armistice Capital, an estimated $16.1M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q1 2026 was Renaissance Technologies, an estimated $1.83M sold.

Based on aggregated 13F filings for Q1 2026.